Medical Startup Failure: Why 75% Fail in the US #shorts
10 Jan 2026 · 0 min

0:23
In this short video, Stacy Chin states that more than 75% of U.S.-based medical startups ultimately fail. She attributes this high failure rate primarily to the extreme complexity of the U.S. healthcare ecosystem, emphasizing the myriad rules and FDA regulatory requirements that startups must navigate to bring medical devices, therapeutics, or other healthcare products through the development pipeline.










